Tumor Type

Japan
Liver Cancer - Hepatocellular carcinoma (Virus associated)
Funding Organizations
Japan: National Institute of Biomedical Innovation
Japan: RIKEN
Research Organizations
Japan: National Cancer Center
Japan: RIKEN
Japan: HGC-IMS, University of Tokyo
Japan: Research Center for Advanced Science and Technology, University of Tokyo
Japan: Hiroshima University, Faculty of Medicine
Japan: Osaka Medical Center for Cancer & Cardiovascular Diseases
Japan: Wakayama Medical University
Research Activities
Publication Policy
1:   ICGC Goals, Structure, Policies and Guidelines Section E.3 - Publication Policy HTML 
2:   Template Letters to Facilitate Communications HTML 
to ensure appropriate dialogue between data users and generators and for authors to contact ICGC members and editors
3:   NCC Project Specific Moratorium HTML 
4:   Riken Project Specific Moratorium HTML 
Clinic & Pathology
Japan: National Cancer Center
Hiroshima University, Faculty of Medicine
Osaka Medical Center for Cancer & Cardiovascular Diseases
Wakayama Medical University
Sequencing & Analysis
Japan: RIKEN
National Cancer Center
HGC-IMS, University of Tokyo
Complementary Studies
Japan: National Cancer Center
RIKEN
Research Center for Advanced Science and Technology, University of Tokyo
HGC-IMS, University of Tokyo
Data Storage, Analysis & Management
Japan: RIKEN
National Cancer Center
HGC-IMS, University of Tokyo
Project Summary

This project aims to elucidate the comprehensive somatic changes in the genome (mutation, rearrangement and copy number change), the epigenome (methylation etc.) and transcriptome of virus (both HBV and HCV)-associated hepatocellular carcinoma as an international contribution.

Principal Investigators

• Yusuke Nakamura
• Tatsuhiro Shibata

Lead Jurisdiction